SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 309 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $98,000 | -99.7% | 571 | -99.8% | 0.00% | -99.7% |
Q4 2014 | $29,625,000 | -9.6% | 257,750 | +22.9% | 1.07% | -7.9% |
Q3 2014 | $32,759,000 | +114.0% | 209,673 | +69.0% | 1.16% | +135.8% |
Q2 2014 | $15,306,000 | +54.3% | 124,088 | +29.6% | 0.49% | +66.4% |
Q1 2014 | $9,920,000 | +0.5% | 95,749 | -12.8% | 0.30% | +8.1% |
Q4 2013 | $9,870,000 | +29.0% | 109,747 | -4.1% | 0.27% | +24.1% |
Q3 2013 | $7,653,000 | -28.4% | 114,439 | -29.2% | 0.22% | -35.9% |
Q2 2013 | $10,691,000 | – | 161,622 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |